Apr. 8, 2025 Discovery of Mitochondrial Protein Opens Path to Therapeutic Advances for Heart and Alzheimer’s Disease By Katz CommunicationsCalcium transport into and out of mitochondria – the powerhouses of cells – is central to cellular […] Apr. 3, 2025 Researchers Identify New Targeted Approach to Protect Neurons Against Degeneration By Katz CommunicationsNeurodegenerative conditions such as Parkinson’s disease and Alzheimer’s involve progressive […] Mar. 27, 2025 Dr. Joanne Garbincius Wins the Louis N. and Arnold M. Katz Basic Science Research Prize By Katz CommunicationsDr. Joanne Garbincius, PhD, Instructor in the Elrod Laboratory in the Aging + Cardiovascular […] Feb. 26, 2025 Kaitlyn Grando’s Groundbreaking Work in Biofilm Research By Katz CommunicationsWhen Kaitlyn Grando, a PhD student in the Biomedical Sciences, Infectious Disease and Immunity […] Dec. 18, 2024 Pete Vulfson’s Journey to Katz: Embracing Opportunity and Knowledge By Katz CommunicationsAs a first-year PhD student at the Lewis Katz School of Medicine, Pete Vulfson is excited to share […] Dec. 18, 2024 Jay Talsania, MD ’91: Healing Hands Across Borders By Katz CommunicationsA Temple-Made Commitment: Purpose in Service Dr. Jay Talsania’s journey with the Guatemala Healing […] Dec. 2, 2024 Reducing Risk of Opioid Addiction While Continuing to Alleviate Pain By Katz CommunicationsIncreasing the levels of chemicals naturally produced in the body called endocannabinoids may […] Nov. 22, 2024 Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University By Katz CommunicationsA novel “on-the-table” (OTT) therapeutic strategy with a total procedure time of less than one hour […] Oct. 7, 2024 Researchers From Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center Reveal Surprising Mechanism for Activating DNA Repair in Cancer By Katz CommunicationsAn enzyme called DNA polymerase theta plays a key role in repairing DNA damage to cancer cells, […] Jun. 12, 2024 New Grant from Alzheimer’s Association Allows Lewis Katz School of Medicine Researchers Opportunity to Identify Rejuvenation Pathways in the Brain, Reversing Cognitive Decline By Katz CommunicationsRecognizing late-life depression as a significant precursor to Alzheimer's disease, primarily due […] Aug. 17, 2023 Novel Treatment Based on Gene Editing Safely and Effectively Removes HIV-Like Virus from Genomes of Non-Human Primates By Katz Communications (Philadelphia, PA) – A single injection of a novel CRISPR gene-editing treatment safely and […] May 3, 2023 Chances of Eliminating HIV Infection Increased by Novel Dual Gene-Editing Approach By Katz CommunicationsGene-editing therapy aimed at two targets – HIV-1, the virus that causes AIDS, and CCR5, the […] Apr. 26, 2023 Existing Drugs Prevent Alzheimer’s Disease-Related Cognitive Impairment in Mice, New Research at The Lewis Katz School of Medicine at Temple University Shows By Katz CommunicationsChanges in blood vessels in the brain linked to the build-up of a sticky protein known as amyloid […] Sep. 21, 2022 First Individual Treated with CRISPR-Based HIV Therapy, a Breakthrough Treatment Pioneered by Researchers at Lewis Katz School of Medicine at Temple University and Developed by Excision BioTherapeutics By Katz CommunicationsIn a major milestone in the search for a cure for HIV/AIDS, a breakthrough gene-editing therapy for […] Jul. 13, 2022 New $4M NIH Grant Awarded to Researchers at Lewis Katz School of Medicine to Fund Groundbreaking Research on Disparities in Hepatitis B and Liver Disease in Asian-Americans By Katz CommunicationsAmong the 2.4 million Americans living with chronic hepatitis B virus (HBV), Asian-Americans are […] Load More
Apr. 8, 2025 Discovery of Mitochondrial Protein Opens Path to Therapeutic Advances for Heart and Alzheimer’s Disease By Katz CommunicationsCalcium transport into and out of mitochondria – the powerhouses of cells – is central to cellular […] Apr. 3, 2025 Researchers Identify New Targeted Approach to Protect Neurons Against Degeneration By Katz CommunicationsNeurodegenerative conditions such as Parkinson’s disease and Alzheimer’s involve progressive […] Mar. 27, 2025 Dr. Joanne Garbincius Wins the Louis N. and Arnold M. Katz Basic Science Research Prize By Katz CommunicationsDr. Joanne Garbincius, PhD, Instructor in the Elrod Laboratory in the Aging + Cardiovascular […] Feb. 26, 2025 Kaitlyn Grando’s Groundbreaking Work in Biofilm Research By Katz CommunicationsWhen Kaitlyn Grando, a PhD student in the Biomedical Sciences, Infectious Disease and Immunity […] Dec. 18, 2024 Pete Vulfson’s Journey to Katz: Embracing Opportunity and Knowledge By Katz CommunicationsAs a first-year PhD student at the Lewis Katz School of Medicine, Pete Vulfson is excited to share […] Dec. 18, 2024 Jay Talsania, MD ’91: Healing Hands Across Borders By Katz CommunicationsA Temple-Made Commitment: Purpose in Service Dr. Jay Talsania’s journey with the Guatemala Healing […] Dec. 2, 2024 Reducing Risk of Opioid Addiction While Continuing to Alleviate Pain By Katz CommunicationsIncreasing the levels of chemicals naturally produced in the body called endocannabinoids may […] Nov. 22, 2024 Major Advances in Treating Lung Blood Clots Could Eliminate Need for ICU Stay, According to New Research at the Lewis Katz School of Medicine at Temple University By Katz CommunicationsA novel “on-the-table” (OTT) therapeutic strategy with a total procedure time of less than one hour […] Oct. 7, 2024 Researchers From Fels Cancer Institute for Personalized Medicine and Fox Chase Cancer Center Reveal Surprising Mechanism for Activating DNA Repair in Cancer By Katz CommunicationsAn enzyme called DNA polymerase theta plays a key role in repairing DNA damage to cancer cells, […] Jun. 12, 2024 New Grant from Alzheimer’s Association Allows Lewis Katz School of Medicine Researchers Opportunity to Identify Rejuvenation Pathways in the Brain, Reversing Cognitive Decline By Katz CommunicationsRecognizing late-life depression as a significant precursor to Alzheimer's disease, primarily due […] Aug. 17, 2023 Novel Treatment Based on Gene Editing Safely and Effectively Removes HIV-Like Virus from Genomes of Non-Human Primates By Katz Communications (Philadelphia, PA) – A single injection of a novel CRISPR gene-editing treatment safely and […] May 3, 2023 Chances of Eliminating HIV Infection Increased by Novel Dual Gene-Editing Approach By Katz CommunicationsGene-editing therapy aimed at two targets – HIV-1, the virus that causes AIDS, and CCR5, the […] Apr. 26, 2023 Existing Drugs Prevent Alzheimer’s Disease-Related Cognitive Impairment in Mice, New Research at The Lewis Katz School of Medicine at Temple University Shows By Katz CommunicationsChanges in blood vessels in the brain linked to the build-up of a sticky protein known as amyloid […] Sep. 21, 2022 First Individual Treated with CRISPR-Based HIV Therapy, a Breakthrough Treatment Pioneered by Researchers at Lewis Katz School of Medicine at Temple University and Developed by Excision BioTherapeutics By Katz CommunicationsIn a major milestone in the search for a cure for HIV/AIDS, a breakthrough gene-editing therapy for […] Jul. 13, 2022 New $4M NIH Grant Awarded to Researchers at Lewis Katz School of Medicine to Fund Groundbreaking Research on Disparities in Hepatitis B and Liver Disease in Asian-Americans By Katz CommunicationsAmong the 2.4 million Americans living with chronic hepatitis B virus (HBV), Asian-Americans are […]
